Zydus Pharmaceuticals (USA) Inc recalls Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahme
Recalled June 12, 2024 · FDA recall D-0542-2024 · Zydus Pharmaceuticals (USA)
Hazard
Failed Impurities/Degradation Specifications. · FDA Class III
Units
21,360 units
Sold at
Nationwide within the United States
Description
Failed Impurities/Degradation Specifications.
Product
Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8
Manufacturer(s)
Zydus Pharmaceuticals (USA) Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →